Canine Antioxidant Composition via Polyphenol Molecular Weight Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antioxidant solutions for dogs are either ineffective in reducing oxidative stress or have high toxicity, lacking in bioavailability and tolerability, which complicates their use in treating chronic degenerative and inflammatory conditions.
Innovation Solution
A composition combining a polyphenol extract from sugar cane with a molecular weight of 600 to 1000 Daltons and silymarin, optionally with vitamins C and E, providing a natural and highly effective antioxidant treatment that is well-tolerated by dogs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antioxidant solutions are used in dogs, then oxidative stress reduction is attempted, but toxicity increases and bioavailability decreases
Solution Approach 1:
The patent changes the molecular weight parameter of polyphenols from conventional high molecular weight to a specific range of 600-1000 Daltons. This parameter change improves bioavailability and reduces toxicity while maintaining antioxidant effectiveness, directly resolving the contradiction between oxidative stress reduction and harmful effects
Solution Approach 2:
The patent creates a composite antioxidant composition combining polyphenol extract (600-1000 Daltons) with silymarin and optionally vitamins C and E. This composite formulation synergistically improves oxidative stress reduction while the specific composition controls toxicity and enhances bioavailability
2Reliability
If conventional antioxidant solutions are used in dogs, then oxidative stress reduction is attempted, but bioavailability decreases
Solution Approach 1:
The patent optimizes the molecular weight parameter of polyphenols to 600-1000 Daltons, which significantly improves absorption and bioavailability in dogs compared to conventional high molecular weight polyphenols, while maintaining antioxidant activity
Solution Approach 2:
The patent uses silymarin as an intermediary substance that enhances the bioavailability of polyphenols. Silymarin acts as a carrier or facilitator that improves the absorption and utilization of polyphenolic compounds in the canine body
3Reliability
If high molecular weight polyphenols are used, then antioxidant activity is maintained, but bioavailability and tolerability decrease
Solution Approach 1:
The patent changes the molecular weight parameter from high molecular weight to a optimized range of 600-1000 Daltons. This parameter optimization maintains sufficient antioxidant activity while dramatically improving bioavailability and tolerability in dogs
Solution Approach 2:
The patent focuses on creating a specific local quality in the polyphenol structure by selecting compounds with molecular weight of 600-1000 Daltons. This specific quality selection achieves the optimal balance between antioxidant efficacy and biological utilization
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly reduces oxidative stress in dogs by effectively neutralizing free radicals, improving clinical and biochemical parameters, and demonstrating high bioavailability and tolerability, even in elderly and diseased animals, with notable results within 60 days of treatment.
Implementation Method 1
These molecules with antioxidant action are able to neutralize free radicals as soon as they are formed
Implementation Method 2
presenting the lowest possible toxicity as well as a high bioavailability
Data Source
AI summary
An antioxidant composition is described for reducing oxidative stress in dogs. In particular, said composition has proved to be particularly suitable in that, in addition to being surprisingly effective, it is extremely well tolerated by the organism as it comprises natural components such as polyphenols and silymarin.